Sourasky Medical Center (Ichilov)
Pancreatic cancer treatment cost in Israel typically involves a diagnostic PET/CT scan ranging from $1,300 to $1,800 and primary pancreatic cancer surgery which runs $38,000 to $61,000. Total expenses depend on the tumor stage, chosen surgical approach, and hospital stay duration. Patients can expect 20-40% savings compared to the US. Top cities for this treatment include Tel Aviv, Jerusalem, and Haifa.
Typical Pancreatic Cancer Treatment Costs in Israel
Bookimed Expert Insight: Patients seeking high-volume surgical expertise should consider Sourasky Medical Center, which performs 34,000 surgeries annually. For complex cases, choosing a JCI-accredited facility like Assuta allows patients to select specific top-tier surgeons. Sourasky offers specialized diagnostic packages starting around $3,950. Those requiring multidisciplinary care benefit from Hadassah Medical Center, where Forbes-listed specialists lead the gastrointestinal cancer division.
| Izrael | Turcja | Austria | |
| Terapia protonowa | od $48,000 | od $70,000 | od $80,000 |
| Procedura Whipple’a | od $45,000 | od $23,000 | od $45,000 |
| Operacja raka trzustki | od $38,000 | od $9,000 | od $40,000 |
| Nano-nóż | od $18,500 | od $9,500 | od $25,000 |
| Gamma Knife | od $13,800 | od $6,300 | od $32,000 |
Dr Sharon Peles specjalizuje się w nowotworach układu pokarmowego. Szkoliła się w prestiżowym centrum onkologicznym Royal Marsden Cancer Center w Londynie.
Prof. Merimsky specjalizuje się w raku trzustki i posiada wieloletnie doświadczenie w onkologii zdobyte w Centrum Medycznym Sourasky.
Prof. Nadir Arber od ponad 30 lat koncentruje się wyłącznie na nowotworach układu pokarmowego. Kieruje Centrum Profilaktyki Raka w renomowanym izraelskim Centrum Medycznym Sourasky.
Dr. Arnon Nagler is a hematologist at Sheba Medical Center in Israel. He is a professor at Tel Aviv University and a renowned transplant expert. Dr. Nagler founded Israel’s first public cord blood bank. He also performed the first cord blood transplantations in the country. He completed postdoctoral training at Stanford University and is board-certified in hematology.
Israeli hospitals provide advanced pancreatic care including NanoKnife irreversible electroporation, which uses electrical pulses to destroy tumours near vital vessels. Centres like Sheba and Sourasky Medical Center offer robotic Whipple procedures and pioneering molecular therapies such as OncoSil microparticles for inoperable cases.
Bookimed Expert Insight: Israeli oncology centres like Sourasky and Sheba report a 90% success rate in oncology treatments through a high-volume approach. Experts such as Prof. Joseph Klauzner have over 45 years of experience in pancreatic surgery. Patients can access comprehensive diagnostic packages that include PET/CT and specialist consultations for approximately A$70,400, often leading to surgical eligibility for cases previously deemed inoperable.
Patient Consensus: Patients in Israel value the clear communication during telehealth consultations and the aggressive surgical assessments for complex cases. Many recommend sending pathology slides for a second opinion before travelling to ensure the most effective treatment plan.
Major Israeli medical centres report success rates between 85% and 90% for complex pancreatic cancer surgeries. JCI-accredited facilities maintain a 90% oncology treatment success rate overall. Specialist high-volume centres reduce procedural risks by 66% compared to smaller clinics. These outcomes include technically demanding procedures like the Whipple surgery.
Bookimed Expert Insight: Israeli oncology centres like Sourasky treat 400,000+ patients annually. This massive volume allows specialists to refine robotic techniques that improve precision during Whipple procedures. While a diagnostics-only package costs around A$5,400, surgeries like the Whipple at Sheba Medical Center typically reach A$55,200. These comprehensive packages include 14 hotel nights for recovery, which is vital for managing post-operative healing safely.
Patient Consensus: Patients note the importance of quick surgical timelines in Israel. They value clear communication during video consultations and the compassionate care provided by specialists like Dr Ofer Merimsky.
Leading medical centres in Israel for pancreatic cancer include Sheba Medical Center and Sourasky Medical Center. These JCI-accredited facilities offer multidisciplinary care. They specialise in complex Whipple procedures and advanced therapies like SIRT. Specialist teams manage diagnosis through to surgery and systemic treatments.
Bookimed Expert Insight: Israeli oncology centres show a clear specialization pattern in high-volume surgical expertise. Dr Joseph Klauzner at Sourasky has over 45 years of experience. Professor Ido Nachmany at Sheba is a Forbes-recognised specialist. This depth of experience is why these clinics maintain high success rates in complex pancreatic resections.
Patient Consensus: Patients value how quickly Israeli teams organise staging tests and multidisciplinary reviews. They highlight the kindness and professional competence of doctors during intensive treatments.
Obtaining a remote second opinion from Israeli specialists requires providing comprehensive electronic medical records, translated diagnostic reports, and uncompressed imaging files. Leading facilities like Sheba Medical Center and Sourasky Medical Center use these files to assess case suitability and determine treatment resectability before virtual consultations.
Bookimed Expert Insight: Israeli specialists often require a histopathology revision of original biopsy slides. Centres like Sourasky Medical Center serve over 400,000 patients and maintain a 90% oncology success rate. Sending physical tissue blocks early can prevent delays if the initial digital review suggests surgical options like the Whipple procedure.
Patient Consensus: Patients highlight that organizing a clear medical timeline and providing recent PET-CT scans ensures faster responses. They appreciate the professional organization of virtual meetings and the ability to ask follow-up questions in Israel.